FDA.reportPublic FDA data

Application 091392

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001METOCLOPRAMIDE HYDROCHLORIDEMETOCLOPRAMIDE HYDROCHLORIDEINJECTABLE;INJECTIONEQ 5MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51662-1367METOCLOPRAMIDEMETOCLOPRAMIDEHF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1367METOCLOPRAMIDEMETOCLOPRAMIDEHF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1367METOCLOPRAMIDEMETOCLOPRAMIDEHF Acquisition Co LLC, DBA HealthFirstANDACurrent
76045-101MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-101MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-101MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-101MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-101MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-213MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent
76045-213MetoclopramideMetoclopramide HydrochlorideFresenius Kabi USA, LLCANDACurrent